Documentos relacionados

1. Macrophage exosomes transfer angiotensin II type 1 receptor to lung fibroblasts mediating bleomycin-induced pulmonary fibrosis.
2. Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing.
3. Dichotomous Roles of <i>Men1</i> in Macrophages and Fibroblasts in Bleomycin-Induced Pulmonary Fibrosis.
4. Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway.
5. TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling.
6. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
7. Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-ß1 signaling pathway.
8. CG223, a novel BET inhibitor, exerts TGF-ß1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis.
9. Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis.
10. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.